Literature DB >> 12570954

Limitation of cardiac output by total isovolumic time during pharmacologic stress in patients with dilated cardiomyopathy: activation-mediated effects of left bundle branch block and coronary artery disease.

Alison M Duncan1, Darrel P Francis, Michael Y Henein, Derek G Gibson.   

Abstract

OBJECTIVES: We sought to separate the effects of associated left bundle branch block (LBBB) and coronary artery disease (CAD) on peak cardiac output (CO) during dobutamine stress in patients with dilated cardiomyopathy (DCM).
BACKGROUND: The mechanisms limiting CO during stress in patients with DCM are unclear. Both LBBB and CAD may do so by prolonging the total isovolumic time (t-IVT).
METHODS: A total of 59 patients with DCM-34 with CAD (20 normal activation [NA], 14 LBBB) and 25 without CAD (15 NA, 10 LBBB)-were studied. The total IVT (s/min; calculated as: 60 - [total ejection time + total filling time] ) and CO were measured by Doppler echocardiography.
RESULTS: At rest, t-IVT was 8 s/min longer with LBBB (p < 0.001), was unaffected by CAD, and did not correlate with rest CO. During stress, CO correlated with t-IVT (r = -0.73, p < 0.001) in all four patient groups. In the absence of CAD, t-IVT became shortened (NA by 7 +/- 3 s/min; LBBB by 9 +/- 4 s/min) and correlated with a fall in the QRS duration (NA: r = 0.87; LBBB: r = 0.91), and CO increased with stress (NA by 4.7 +/- 2.7 l/min; LBBB by 4.0 +/- 2.3 l/min; all p < 0.001). With CAD, t-IVT did not shorten normally with stress. Instead, t-IVT was 5.6 s/min longer and CO was 3.3 l/min lower than in those without CAD (both p < 0.001), and t-IVT did not correlate with the QRS duration.
CONCLUSIONS: In patients with DCM, t-IVT during pharmacologic stress depends on changes in ventricular activation induced by LBBB or CAD and is, by itself, a major determinant of peak CO during stress.

Entities:  

Mesh:

Year:  2003        PMID: 12570954     DOI: 10.1016/s0735-1097(02)02665-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Role of Electromechanical Dyssynchrony Assessment During Acute Circulatory Failure and Its Relation to Ventriculo-Arterial Coupling.

Authors:  Stefan Andrei; Bogdan A Popescu; Vincenza Caruso; Maxime Nguyen; Belaid Bouhemad; Pierre-Grégoire Guinot
Journal:  Front Cardiovasc Med       Date:  2022-06-21

2.  Effect of endovascular stenting of aortic coarctation on biventricular function in adults.

Authors:  Yat-Yin Lam; Mehmet G Kaya; Wei Li; Vaikom S Mahadevan; Arif A Khan; Michael Y Henein; Michael Mullen
Journal:  Heart       Date:  2007-06-17       Impact factor: 5.994

Review 3.  Echocardiographic prediction of outcome after cardiac resynchronization therapy: conventional methods and recent developments.

Authors:  Geert E Leenders; Maarten J Cramer; Margot D Bogaard; Mathias Meine; Pieter A Doevendans; Bart W De Boeck
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

4.  Effect of changes in contractility on the index of myocardial performance in the dysfunctional left ventricle.

Authors:  Steven J Lavine
Journal:  Cardiovasc Ultrasound       Date:  2006-11-17       Impact factor: 2.062

Review 5.  Expert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failure.

Authors:  Susanna Price; Elke Platz; Louise Cullen; Guido Tavazzi; Michael Christ; Martin R Cowie; Alan S Maisel; Josep Masip; Oscar Miro; John J McMurray; W Frank Peacock; F Javier Martin-Sanchez; Salvatore Di Somma; Hector Bueno; Uwe Zeymer; Christian Mueller
Journal:  Nat Rev Cardiol       Date:  2017-04-27       Impact factor: 32.419

6.  Different effect of exercise on left ventricular diastolic time and interventricular dyssynchrony in heart failure patients with and without left bundle branch block.

Authors:  Gunnar Plehn; Julia Vormbrock; Thomas Butz; Martin Christ; Hans-Joachim Trappe; Axel Meissner
Journal:  Int J Med Sci       Date:  2008-11-04       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.